First-in-human phase I study of BPI-9016M, a dual MET/Axl...

Journal of Hematology & Oncology 2020 / 12 Vol. 13; Iss. 1

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Hu, Xingsheng, Zheng, Xin, Yang, Sheng, Wang, Lin, Hao, Xuezhi, Cui, Xinge, Ding, Lieming, Mao, Li, Hu, Pei, Shi, Yuankai
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-019-0834-2
Date:
December, 2020
File:
PDF, 937 KB
2020
Conversion to is in progress
Conversion to is failed